1887

Abstract

Equine herpesvirus type 1 (EHV-1) is the causative agent of equine herpes myeloencephalopathy, of which outbreaks are reported with increasing frequency throughout North America and Europe. This has resulted in its classification as a potentially emerging disease by the US Department of Agriculture. Recently, it was found that a single nucleotide polymorphism (SNP) in the viral DNA polymerase gene (ORF30) at aa 752 (N→D) is associated with the neurovirulent potential of EHV-1. In the present study, equine respiratory mucosal explants were inoculated with several Belgian isolates typed in their ORF30 as D or N, to evaluate a possible difference in replication in the upper respiratory tract. In addition, to evaluate whether any observed differences could be attributed to the SNP associated with neurovirulence, the experiments were repeated with parental Ab4 (reference neurovirulent strain), parental NY03 (reference non-neurovirulent strain) and their N/D revertant recombinant viruses. The salient findings were that EHV-1 spreads plaquewise in the epithelium, but plaques never cross the basement membrane (BM). However, single EHV-1-infected cells could be observed below the BM at 36 h post-inoculation (p.i.) for all N isolates and at 24 h p.i. for all D isolates, and were identified as monocytic cells and T lymphocytes. Interestingly, the number of infected cells was two to five times higher for D isolates compared with N isolates at every time point analysed. Finally, this study showed that equine respiratory explants are a valuable and reproducible model to study EHV-1 neurovirulence , thereby reducing the need for horses as experimental animals.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.019257-0
2010-08-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/8/2019.html?itemId=/content/journal/jgv/10.1099/vir.0.019257-0&mimeType=html&fmt=ahah

References

  1. Allen G. P. 2008; Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses. Am J Vet Res 69:1595–1600
    [Google Scholar]
  2. Allen G. P., Breathnach C. C. 2006; Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1. Equine Vet J 38:252–257
    [Google Scholar]
  3. Allen G. P., Bryans J. T. 1986; Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog Vet Microbiol Immunol 2:78–144
    [Google Scholar]
  4. Awan A. R., Chong Y.-C., Field H. J. 1990; The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J Gen Virol 71:1131–1140
    [Google Scholar]
  5. Brosnahan M. M., Osterrieder N. 2009; Equine herpesvirus-1: a review and update. In Infectious Diseases of the Horse pp 41–51 Edited by Mair T. S., Hutchinson R. E. Fordham: Equine Veterinary Journal;
    [Google Scholar]
  6. Bryans J. T., Allen G. P. 1989; Herpesviral diseases of the horse. In Herpesviral Diseases of Cattle, Horses and Pigs pp 176–229 Edited by Wittman G. Boston: Kluwer;
    [Google Scholar]
  7. Galosi C. M., Barbeito C. G., Vila Rosa M. V., Cid de la Paz V., Ayala M. A., Corva S. G., Etcheverrigaray M. E., Gimeno E. J. 2004; Argentine strain of equine herpesvirus 1 isolated from an aborted foetus shows low virulence in mouse respiratory and abortion models. Vet Microbiol 103:1–12
    [Google Scholar]
  8. Gibson J. S., Slater J. D., Awan A. R., Field H. J. 1992; Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Arch Virol 123:351–366
    [Google Scholar]
  9. Glorieux S., Van den Broeck W., van der Meulen K. M., van Reeth K., Favoreel H. W., Nauwynck H. J. 2007; In vitro culture of porcine respiratory nasal mucosa explants for studying the interaction of porcine viruses with the respiratory tract. J Virol Methods 142:105–112
    [Google Scholar]
  10. Glorieux S., Favoreel H. W., Meesen G., de Vos W., Van den Broeck W., Nauwynck H. J. 2009; Different replication characteristics of historical pseudorabies virus strains in porcine respiratory nasal mucosa explants. Vet Microbiol 136:341–346
    [Google Scholar]
  11. Goodman L. B., Wagner B., Flaminio M. J., Sussman K. H., Metzger S. M., Holland R., Osterrieder N. 2006; Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type. 1 (EHV-1). Vaccine 243636–3645
  12. Goodman L. B., Loregian A., Perkins G. A., Nugent J., Buckles E. L., Mercorelli B., Kydd J. H., Palù G., Smith K. C. other authors 2007; A point mutation in a herpesvirus polymerase determines neuropathogenicity. PLoS Pathog 3:e160
    [Google Scholar]
  13. Gryspeerdt A., Vandekerckhove A. P., Garré B., Barbé F., Van de Walle G. R., Nauwynck H. J. 2010; Differences in replication kinetics and cell tropism between neurovirulent and non-neurovirulent EHV1 strains during the acute phase of infection in horses. Vet Microbiol 142:242–253
    [Google Scholar]
  14. Kohn C. W., Reed S. M., Sofaly C. D., Henninger R. W., Saville W. J., Allen G. P., Premanadan C. 2006; Transmission of EHV-1 in horses with EHV-1 myeloencephalopathy: implications for biosecurity and review. Clin Tech Equine Pract 5:60–66
    [Google Scholar]
  15. Kydd J. H., Smith K. C., Hannant D., Livesay G. J., Mumford J. A. 1994a; Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract associated lymphoid tissue: implications for cellular immunity. Equine Vet J 26:470–473
    [Google Scholar]
  16. Kydd J. H., Smith K. C., Hannant D., Livesay G. J., Mumford J. A. 1994b; Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract of ponies: implications for vaccination strategies. Equine Vet J 26:466–469
    [Google Scholar]
  17. Kydd J. H., Townsend H. G., Hannant D. 2006; The equine immune response to equine herpesvirus-1: the virus and its vaccines. Vet Immunol Immunopathol 111:15–30
    [Google Scholar]
  18. Lunn D. P., Davis-Poynter N., Flaminio M. J., Horohov D. W., Osterrieder K., Pusterla N., Townsend H. G. 2009; Equine herpesvirus-1 consensus statement. J Vet Intern Med 23:450–461
    [Google Scholar]
  19. Muylle S., Simoens P., Lauwers H. 1996; Ageing horses by an examination of their incisor teeth: an (im)possible task?. Vet Rec 138:295–301
    [Google Scholar]
  20. Nugent J., Birch-Machin I., Smith K. C., Mumford J. A., Swann Z., Newton J. R., Bowden R. J., Allen G. P., Davis-Poynter N. 2006; Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neurovirulent versus nonneurovirulent disease outbreaks. J Virol 80:4047–4060
    [Google Scholar]
  21. Patel J. R., Heldens J. 2005; Equine herpesviruses 1 (EHV-1) and 4 (EHV-4) – epidemiology, disease and immunoprophylaxis: a brief review. Vet J 170:14–23
    [Google Scholar]
  22. Perkins G. A., Goodman L. B., Tsujimura K., Van de Walle G. R., Kim S. G., Dubovi E. J., Osterrieder N. 2009; Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984–2007. Vet Microbiol 139:375–378
    [Google Scholar]
  23. Pol J. M. A., Gielkens A. L. J., Van Oirschot J. T. 1989; Comparative pathogenesis of three strains of pseudorabies virus in pigs. Microb Pathog 7:361–371
    [Google Scholar]
  24. Pusterla N., Wilson W. D., Madigan J. E., Ferraro G. L. 2009; Equine herpesvirus-1 myeloencephalopathy: a review of recent developments. Vet J 180:279–289
    [Google Scholar]
  25. Sabo A., Rajcani J., Blaskovic D. 1969; Studies on the pathogenesis of Aujeszky's disease. III. The distribution of virulent virus in piglets after intranasal infection. Acta Virol 13:407–414
    [Google Scholar]
  26. Timoney J. F. 2004; The pathogenic equine streptococci. Vet Res 35:397–409
    [Google Scholar]
  27. USDA APHIS 2007; Equine herpesvirus myeloencephalopathy: a potentially emerging disease. Available at: http://www.aphis.usda.gov/animal_health/emergingissues/downloads/ehv1final.pdf. Accessed 9 December 2008. US Department of Agriculture Animal and Plant Health Inspection Service
  28. Vandekerckhove A., Glorieux S., Van den Broeck W., Gryspeerdt A., van der Meulen K. M., Nauwynck H. J. 2009; In vitro culture of equine respiratory mucosa explants. Vet J 181:280–287
    [Google Scholar]
  29. van der Meulen K. M., Vercauteren G., Nauwynck H. J., Pensaert M. B. 2003; A local epidemic of equine herpesvirus 1-induced neurological disorders in Belgium. Flem Vet J 72:366–372
    [Google Scholar]
  30. Van de Walle G. R., Goupil R., Wishon C., Damiani A., Perkins G. A., Osterrieder N. 2009; A single-nucleotide polymorphism in a herpesvirus DNA polymerase is sufficient to cause lethal neurological disease. J Infect Dis 200:20–25
    [Google Scholar]
  31. Van Maanen C. 2002; Equine herpesvirus 1 and 4 infections: an update. Vet Q 24:58–78
    [Google Scholar]
  32. Van Maanen C., Cullinane A. 2002; Equine influenza virus infections: an update. Vet Q 24:79–94
    [Google Scholar]
  33. Van Woensel P. A. M., Goovaerts D., Markx D., Visser N. 1995; A mouse model for testing the pathogenicity of equine herpes virus-1 strains. J Virol Methods 54:39–49
    [Google Scholar]
  34. Walker C., Love D. N., Whalley J. M. 1999; Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse model: a review. Vet Microbiol 68:3–13
    [Google Scholar]
  35. Wyler R., Engels M., Schwyzer M. 1989; Infectious bovine rhinotracheitis/vulvovaginitis (BHV1). In Herpesvirus Diseases of Cattle, Horses, and Pigs . pp 1–72 Edited by Wittman G. Dordrecht: Kluwer Academic Publishers;
  36. Yamada S., Matsumara T., Tsjujimura K., Yamaguchi T., Ohya K., Fukushi H. 2008; Comparison of the growth kinetics of neurovirulent and nonneurovirulent equid herpesvirus type 1 (EHV-1) strains in cultured murine neuronal cells and the relevance of the D/N752 coding change in DNA polymerase gene (ORF30. J Vet Med Sci 70:505–511
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.019257-0
Loading
/content/journal/jgv/10.1099/vir.0.019257-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error